One stop for all your health tips
Blueprint Medicines Corporation today announced the European Commission has approved AYVAKYT® (avapritinib) for the treatment of adult patients with indolent systemic mastocytosis (ISM) with moderate to severe symptoms inadequately controlled on symptomatic treatment. AYVAKYT is the first and only approved therapy for people living with ISM in Europe. Systemic mastocytosis (SM) is a rare hematologic disorder that can […]
Clinical Work With Men: Why We Need Gender-Specific Therapy For Men’s Mental, Emotional, and Relational Health
Inside Canggu’s $60-A-Day Fitness Arms Race
Getting to the Heart of the Matter, Part 3: The Changing Rhythms of Love Through the Ages
Getting to the Heart of the Matter, Part 2: For My Children, Grandchildren & Great Grandchildren
Why It Looks Like Anger, Not Sadness
Real Talk on Dating and Relationships ❤️
